As mentioned above, the nomenclature NAFLD has been changed, first to metabolic (dysfunction)-associated fatty liver disease (MAFLD) [57] and more recently to metabolic dysfunction-associated steatotic liver disease (MASLD) [2]
Wascher T, Schmoelzer I, Wiegratz A, Stuehlinger M, Mueller-Wieland D, Kotzka J, Enderle M: Reduction of postchallenge hyperglycaemia prevents acute endothelial dysfunction in subjects with impaired glucose tolerance
Patients with unmanaged chronic stress, sleep deprivation, or recent trauma also show elevated vulnerability
At the same time, your body prioritizes fat storage around the abdomen, where metabolic activity is lower than in other areas